In the early stage of progressive supranuclear palsy, symptoms can be mild and easy to dismiss. People experiencing these symptoms might think that they’re simply experiencing stress or getting ...

Progressive supranuclear palsy (PSP) is an uncommon brain disorder. It affects many areas of function, including a person's movement, balance, mood and behavior, speech, and thoughts. Damage done ...

Virginia Rep. Jennifer Wexton, a three-term congresswoman, speaks with PEOPLE about her diagnosis of progressive supranuclear palsy — or 'Parkinson's on steroids' — a rare and degenerative ...

Doctors later changed her diagnosis to progressive supranuclear palsy, a similar disorder that impacts only 5 in 100,000 people, according to nonprofit CurePSP.

The Food and Drug Administration (FDA) has received Fast Track designation for FNP-223 for the treatment of progressive supranuclear palsy (PSP). FNP-223, previously known as ASN90, is a ...

The recent discovery of a unique protein pattern in spinal fluid may make earlier diagnosis of progressive supranuclear palsy a reality. Researchers at the University of California San Francisco (CA, ...

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic four-repeat tauopathies that have characteristic clinical and neuropathologic profiles, but also share ...

Epidemiology & Pathogenesis Progressive supranuclear palsy is the most frequent parkinsonian disorder after PD. Its prevalence increases with age. [62] The average annual incidence rate for PSP ...